“…Improper use of SAs, such as excessive administration and an inadequate withdrawal period, may result in sulphonamide residues in milk. These residues are of great public health interest given the risk of developing the growth of an antibiotic-resistant bacteria strain, thus rendering inefficient this type of drug for therapeutic use (Chung, Lee, Chung, & Lee, 2009;Haagsma, Pluijmakers, Aets, & Beek, 1989). Moreover, SA residues are of particular concern given the potential carcinogenic character of some substances, such as sulfamethazine (Littelefield, Sheldon, Allen, & Gaylor, 1990).…”